Amarin Corp PLC (NASDAQ:AMRN): Stock Institutional Investors Are Happy About

Amarin Corporation plc (NASDAQ:AMRN) Logo

Sentiment for Amarin Corp PLC (NASDAQ:AMRN)

Amarin Corp PLC (NASDAQ:AMRN) institutional sentiment increased to 1.65 in Q4 2018. Its up 0.02, from 1.63 in 2018Q3. The ratio increased, as 107 investment professionals opened new or increased stock positions, while 65 trimmed and sold equity positions in Amarin Corp PLC. The investment professionals in our partner’s database reported: 139.69 million shares, up from 126.12 million shares in 2018Q3. Also, the number of investment professionals holding Amarin Corp PLC in their top 10 stock positions increased from 7 to 10 for an increase of 3. Sold All: 18 Reduced: 47 Increased: 41 New Position: 66.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company has market cap of $5.75 billion. The companyÂ’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It currently has negative earnings. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.

The stock decreased 0.46% or $0.08 during the last trading session, reaching $17.39. About 2.21M shares traded. Amarin Corporation plc (NASDAQ:AMRN) has risen 537.69% since May 8, 2018 and is uptrending. It has outperformed by 533.32% the S&P500.

Analysts await Amarin Corporation plc (NASDAQ:AMRN) to report earnings on August, 7. They expect $-0.06 EPS, up 50.00 % or $0.06 from last year’s $-0.12 per share. After $-0.07 actual EPS reported by Amarin Corporation plc for the previous quarter, Wall Street now forecasts -14.29 % EPS growth.

Oracle Investment Management Inc holds 21.96% of its portfolio in Amarin Corporation plc for 5.20 million shares. Apis Capital Advisors Llc owns 1.16 million shares or 21.2% of their US portfolio. Moreover, Consonance Capital Management Lp has 9.46% invested in the company for 9.45 million shares. The Massachusetts-based Opaleye Management Inc. has invested 6.35% in the stock. Baker Bros. Advisors Lp, a New York-based fund reported 42.59 million shares.

Since January 1, 0001, it had 0 buys, and 15 insider sales for $40.01 million activity.

Amarin Corporation plc (NASDAQ:AMRN) Ratings Coverage

Ratings analysis reveals 100% of Amarin’s analysts are positive. Out of 4 Wall Street analysts rating Amarin, 4 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $27 while the high is $51. The stock’s average target of $35.75 is 105.58% above today’s ($17.39) share price. AMRN was included in 10 notes of analysts from February 22, 2019. On Wednesday, February 27 the stock rating was maintained by Jefferies with “Buy”. The stock of Amarin Corporation plc (NASDAQ:AMRN) has “Buy” rating given on Friday, March 8 by Cantor Fitzgerald. The rating was maintained by Cantor Fitzgerald with “Buy” on Friday, February 22. The stock of Amarin Corporation plc (NASDAQ:AMRN) earned “Buy” rating by Cantor Fitzgerald on Friday, March 15. On Thursday, February 28 the stock rating was maintained by H.C. Wainwright with “Buy”. H.C. Wainwright maintained Amarin Corporation plc (NASDAQ:AMRN) rating on Tuesday, March 19. H.C. Wainwright has “Buy” rating and $51 target. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, March 21. The rating was maintained by Cantor Fitzgerald with “Buy” on Friday, March 22.

More notable recent Amarin Corporation plc (NASDAQ:AMRN) news were published by: which released: “Pre-Market Most Active for Apr 23, 2019 : TWTR, STNE, NVS, BP, SNAP, LYFT, KO, STM, SQQQ, AMD, TSLA, AMRN – Nasdaq” on April 23, 2019, also with their article: “Amarin Corporation (AMRN) PT Raised to $23 at Citi Ahead of 5 Catalysts –” published on May 02, 2019, published: “Amarin (AMRN) Beats Estimates for Earnings & Revenues in Q1 – Nasdaq” on May 01, 2019. More interesting news about Amarin Corporation plc (NASDAQ:AMRN) were released by: and their article: “Amarin Q1 2019 Earnings Preview – Seeking Alpha” published on April 30, 2019 as well as‘s news article titled: “Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019 – Nasdaq” with publication date: April 24, 2019.

Amarin Corporation plc (NASDAQ:AMRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.